BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6077953)

  • 21. [Medical treatment of gout in 1968].
    Saporta L; Bontoux D; Menkès C
    Rhumatologie; 1968 Jan; 20(1):3-22. PubMed ID: 5741574
    [No Abstract]   [Full Text] [Related]  

  • 22. [Maintenance therapy of gout].
    Hart FD
    Clin Ter; 1967 Mar; 40(6):511-9. PubMed ID: 5601192
    [No Abstract]   [Full Text] [Related]  

  • 23. [Benzodiarone in the therapy of gout].
    Chériè Lignière G; Solazzi F
    Reumatismo; 1968; 20(1):53-62. PubMed ID: 5708869
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A
    Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
    [No Abstract]   [Full Text] [Related]  

  • 25. [Gout (pathogenesis and therapy)].
    Chirone E
    Policlinico Prat; 1968 Feb; 75(6):177-87. PubMed ID: 5744779
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modern therapy of gout].
    Delbarre F; Saporta L; De Gery A; Panahi F
    Clin Ter; 1968 Jul; 46(2):103-22. PubMed ID: 5704842
    [No Abstract]   [Full Text] [Related]  

  • 27. [Gout--based on 110 cases. II].
    Matusan J; Dubravcić M; Tukić A; Boschi S
    Med Glas; 1968 Dec; 22(12):436-41. PubMed ID: 5199574
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does allopurinol affect the progression of familial juvenile gouty nephropathy?
    Moro F; Simmonds HA; Cameron JS; Ogg CS; Williams GD; McBride MB; Davis PM
    Adv Exp Med Biol; 1991; 309A():199-202. PubMed ID: 1789208
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of gout.
    Drug Ther Bull; 1985 Jun; 23(12):47-8. PubMed ID: 4006748
    [No Abstract]   [Full Text] [Related]  

  • 31. [Gouty nephropathy, treated with allopurinol].
    Gruev I; Chukanov K
    Vutr Boles; 1973; 12(5):150-2. PubMed ID: 4782220
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hyperuricemia in gout and renal insufficiency with benziodarone].
    Richet G; Cottet J; Amiel C; Leroux-Robert C; Podevin R
    Presse Med (1893); 1966 May; 74(24):1247-9. PubMed ID: 5936081
    [No Abstract]   [Full Text] [Related]  

  • 34. Case 1: differential diagnosis of an acute gouty attack.
    Weaver AL
    Am J Med; 2006 Nov; 119(11 Suppl 1):S2-3. PubMed ID: 17059907
    [No Abstract]   [Full Text] [Related]  

  • 35. Allopurinol in gouty nephropathy and renal dialysis.
    Rundles RW
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):694-6. PubMed ID: 5958701
    [No Abstract]   [Full Text] [Related]  

  • 36. What is the pathogenesis of familial gouty nephropathy?
    Cameron JS; Moro F; Simmonds HA
    Adv Exp Med Biol; 1991; 309A():185-9. PubMed ID: 1789204
    [No Abstract]   [Full Text] [Related]  

  • 37. Refractory gout: what is it and what to do about it?
    Fels E; Sundy JS
    Curr Opin Rheumatol; 2008 Mar; 20(2):198-202. PubMed ID: 18349751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gout.
    Smyth CJ
    Clin Orthop Relat Res; 1968; 57():69-80. PubMed ID: 4876121
    [No Abstract]   [Full Text] [Related]  

  • 39. Should asymptomatic hyperuricaemia be treated?
    Jeremy R
    Med J Aust; 1972 Aug; 2(9):505-6. PubMed ID: 5083604
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of hyperuricemia and gout].
    Gröbner W; Walter-Sack I
    Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.